BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 33259905)

  • 21. Management of malignant fungating wounds in advanced cancer.
    Seaman S
    Semin Oncol Nurs; 2006 Aug; 22(3):185-93. PubMed ID: 16893748
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Management of patients with haemorrhage malignant wounds].
    Nicodème M; Cheron M; Labedade É; Fromantin I; Lefort H
    Rev Infirm; 2021; 70(273):27-30. PubMed ID: 34446231
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Malignant fungating wounds: a survey of nurses' clinical practice in Switzerland.
    Probst S; Arber A; Faithfull S
    Eur J Oncol Nurs; 2009 Sep; 13(4):295-8. PubMed ID: 19386546
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Care of patients with fungating malignant wounds.
    Grocott P
    Nurs Stand; 2007 Feb 21-27; 21(24):57-8, 60, 62 passim. PubMed ID: 17345910
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The relationship between malignant wound status and pain in breast cancer patients.
    Tamai N; Mugita Y; Ikeda M; Sanada H
    Eur J Oncol Nurs; 2016 Oct; 24():8-12. PubMed ID: 27697281
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Symptoms of Malignant Fungating Wounds and Functional Performance among Patients with Advanced Cancer: An Integrative Review from 2000 to 2019.
    Tilley CP; Fu MR; Van Cleeve J; Crocilla BL; Comfort CP
    J Palliat Med; 2020 Jun; 23(6):848-862. PubMed ID: 32349622
    [No Abstract]   [Full Text] [Related]  

  • 27. General principles and approaches to wound prevention and care at end of life: an overview .
    Langemo D
    Ostomy Wound Manage; 2012 May; 58(5):24-6, 28, 30 passim. PubMed ID: 22562937
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Malignant fungating wounds: the meaning of living in an unbounded body.
    Probst S; Arber A; Faithfull S
    Eur J Oncol Nurs; 2013 Feb; 17(1):38-45. PubMed ID: 22459257
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Hemorrhagic incidents during prolonged ambulatory treatment with acenocoumarol].
    Reverter JC; Tàssies D; Maragall S; Monteagudo J; Escolar G; Ordinas A
    Med Clin (Barc); 1995 Jun; 105(4):127-30. PubMed ID: 7623503
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Factors associated with the time to first palliative care consultation in Lebanese cancer patients.
    Bakouny Z; Assi T; El Rassy E; Daccache K; Kattan C; Tohme A; Mouhawej MC; Kattan J
    Support Care Cancer; 2019 Apr; 27(4):1529-1533. PubMed ID: 30406426
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characteristics and Outcomes of Advanced Cancer Patients Who Received Palliative Care at a Public Hospital Compared with Those at a Comprehensive Cancer Center.
    Delgado-Guay MO; Ferrer J; Ochoa J; Cantu H; Williams JL; Park M; Bruera E
    J Palliat Med; 2018 May; 21(5):678-685. PubMed ID: 29451835
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Guideline-based Care for patients with malignant lesions : The new S3 guideline for patients with incurable cancer].
    Uebach B; Krull E; Simon ST; Bausewein C; Voltz R; Doll A;
    HNO; 2022 Mar; 70(3):167-178. PubMed ID: 35171305
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hemorrhagic complications in patients with advanced hematological malignancies followed at home: an Italian experience.
    Cartoni C; Niscola P; Breccia M; Brunetti G; D'Elia GM; Giovannini M; Romani C; Scaramucci L; Tendas A; Cupelli L; de Fabritiis P; Foa R; Mandelli F
    Leuk Lymphoma; 2009 Mar; 50(3):387-91. PubMed ID: 19347728
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Wounds in advanced illness: a prevalence and incidence study based on a prospective case series.
    Maida V; Corbo M; Dolzhykov M; Ennis M; Irani S; Trozzolo L
    Int Wound J; 2008 Jun; 5(2):305-14. PubMed ID: 18494636
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Symptoms associated with malignant wounds: a prospective case series.
    Maida V; Ennis M; Kuziemsky C; Trozzolo L
    J Pain Symptom Manage; 2009 Feb; 37(2):206-11. PubMed ID: 18619764
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Malignant Wounds in Hospitalized Oncology Patients: Prevalence, Characteristics, and Associated Factors.
    Firmino F; Ferreira SADC; Franck EM; de Queiroz WMS; Castro DV; Nogueira PC; Santos VLCG
    Plast Surg Nurs; 2020; 40(3):138-144. PubMed ID: 32852440
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transition Points for the Routine Integration of Palliative Care in Patients With Advanced Cancer.
    Collins A; Sundararajan V; Burchell J; Millar J; McLachlan SA; Krishnasamy M; Le BH; Mileshkin L; Hudson P; Philip J
    J Pain Symptom Manage; 2018 Aug; 56(2):185-194. PubMed ID: 29608934
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hemostatic dressings in civil prehospital practice: 30 uses of QuikClot Combat Gauze.
    Travers S; Lefort H; Ramdani E; Lemoine S; Jost D; Bignand M; Tourtier JP
    Eur J Emerg Med; 2016 Oct; 23(5):391-4. PubMed ID: 26351975
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The management of malodour and exudate in fungating wounds.
    Draper C
    Br J Nurs; 2005 Jun 9-22; 14(11):S4-12. PubMed ID: 15976610
    [TBL] [Abstract][Full Text] [Related]  

  • 40. New hemostatic agents in the combat setting.
    Cox ED; Schreiber MA; McManus J; Wade CE; Holcomb JB
    Transfusion; 2009 Dec; 49 Suppl 5():248S-55S. PubMed ID: 19954487
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.